(Q73323687)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Berton M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Allémann E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Stein CA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gurny R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmaceutical Sciences

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

163-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Antisense oligonucleotides: is the glass half full or half empty?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV).

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Delivery of oligonucleotides and polynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Cationic lipid-based gene delivery systems: pharmaceutical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Gene transfer vectors based on Sendai virus

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Ultrasound-induced degradation of PLA and PLGA during microsphere processing: influence of formulation variables

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Effects of synthetic oligonucleotides on human complement and coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Phosphorothioate antisense oligodeoxynucleotides: questions of specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

Mechanism of oligonucleotide release from cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2899%2900049-4

7 January 2021

10.1016/S0928-0987(99)00049-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10620729%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference